The largest database of trusted experimental protocols

39 protocols using sodium citrate buffer

1

Streptozotocin-Induced Diabetic Rat Retina Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
All procedures with animals were performed in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and were approved by the Institutional Animal Care and Use Committee of the College of Pharmacy, King Saud University. Adult male Sprague-Dawley rats, 8–9 weeks of age weighing in the range of 220–250 g were overnight fasted, and streptozotocin (STZ; 65 mg/kg in 50 mM sodium citrate buffer, pH 4.5; Sigma, St. Louis, MO) was injected intraperitoneally as a single bolus. Equal volumes of citrate buffer were injected in non-diabetic control animals. Measurement of blood glucose concentrations and bodyweights were started 3 days after injection of STZ. Diabetes was confirmed by assaying the glucose concentration in blood taken from the tail vein. Rats with glucose levels >250 mg/dl were categorized as diabetic. After 4 weeks of diabetes, animals were anesthetized by intraperitoneal injection of an overdose of chloral hydrate and euthanized by decapitation. Retinas were dissected, flash frozen, and stored at −80 °C until use. Similarly, retinas were obtained from age-matched nondiabetic control rats.
+ Open protocol
+ Expand
2

Streptozotocin-Induced Diabetes Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Streptozotocin (Sigma-Aldrich, St-Louis, MO, USA) was dissolved in sodium citrate buffer (Sigma-Aldrich, pH 4.5) at a concentration of 22.5 mg/ml. A dose of 35 mg/kg was immediately injected intraperitoneally. The STZ solution must be extemporaneously prepared38 (link).
+ Open protocol
+ Expand
3

Radiolabeling of Anti-CAIX Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human IgG1 antimouse
CAIX (mCAIX, clone MSC3, Creative Biolabs) (molecular weight: 150
kDa), which reacts with both human and murine CAIX, and human IgG1-irrelevant
control antibody (hIgG1, BioXCell) (molecular weight: 150 kDa) were
conjugated in a molar ratio of 1:15 with isothiocyanatobenzyl–diethylenetriaminepentaacetic
acid (ITC–DTPA, Macrocyclis) in NaHCO3 (pH 9.5)
for 1 h at room temperature (resulting in a DTPA/antibody ratio of
3.4:1). The conjugated antibody was dialyzed against NH4Ac (0.25 M, pH 5.5) to remove the unbound chelator. DTPA-conjugated
antibodies were radiolabeled with indium-111 (111In, Curium)
after adding a twofold volume of 2-(N-morpholino)ethanesulfonic
acid (0.5 M MES, pH 5.5) buffer for 30 min at RT. Radiolabeling efficiency
exceeded 95% in all experiments, as determined by instant thin-layer
chromatography on silica gel chromatography strips (ITLC-SG, Agilent
Technologies) in 0.1 M sodium citrate buffer (Sigma Aldrich).
+ Open protocol
+ Expand
4

Ovariectomy and STZ-Induced Diabetes Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
All mice were anaesthetized with pentobarbital sodium (50 mg/kg body weight, ip) and then ovariectomized. An incision was made along the abdominal mid-line, the ovaries were removed from both sides, and then the wound was sutured. After recovering for one week, all animals were injected intraperitoneally with STZ in 0.1 mmol/L sodium citrate buffer, pH 4.5 (Sigma Chemical Co., St. Louis, MO, USA) at a dose of 50 mg/kg/day for 5 consecutive days to induce pancreatic islet cell destruction and persistent hyperglycemia as described previously [22 (link), 23 (link)]. Some of the ovariectomized mice were administered resveratrol or 17β-estradiol (both dissolved in sesame oil, Sigma Chemical Co.) subcutaneously on every other day for 4 weeks, meanwhile at the beginning 5 days, STZ was simultaneously injected at a dose of 50 mg/kg/day intraperitoneally. Blood glucose levels were measured from the caudal vein using a portable glucose measuring device (Roche) once a week. Mice with hyperglycemia (blood glucose levels ≥300 mg/dl) were defined as a diabetic model, as before [23 (link)].
All animal procedures carried out in this study were reviewed, approved, and supervised by the Institutional Animal Care and Use Committee of the Ethics Committee of Lanzhou University, China.
+ Open protocol
+ Expand
5

Troxerutin Ameliorates Diabetic Complications

Check if the same lab product or an alternative is used in the 5 most similar protocols
All procedures involving animals were in accordance with the Guide for the Care and Use of Laboratory Animals. Forty male Sprague-Dawley rats (age 6–8 weeks, from Beijing Vital River Laboratory Animal Technology Co., certificate number 1100195543) were randomly divided into a normal control group (NC group, n = 10 rats) and a diabetic group (n = 30 rats). The rats fasted overnight. Then, STZ was dissolved in 0.1 mol/L sodium citrate buffer, pH 4.4, and the 30 rats were intraperitoneally injected with STZ citrate buffer (60 mg/kg/d, Sigma Company, USA). At 72 hours after the injection, the blood glucose level of the rats was determined via their tail veins using a blood glucose meter. Fasted rats with a blood glucose level above 16.7 mmol/L were considered to be diabetic and were randomly divided between a diabetic control group (DC group, n = 15) and a diabetic troxerutin intervention group (DT group, n = 15).
Rats in the DT group were intraperitoneally injected with troxerutin (60 mg/kg, 1 mL/kg, Jingchun Biochemistry Technology Corporation, Shanghai, China), while those in the DC and NC groups were intraperitoneally injected with physiological saline once daily for 12 weeks. Finally, the blood glucose levels were measured after 12 weeks of troxerutin treatment.
+ Open protocol
+ Expand
6

Chemical Preparation and Sourcing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemicals including absolute ethanol, sulfuric acid, methanol, fructose,
dilute ammonium hydroxide, concentrated ammonium hydroxide, streptozotocin
(STZ), 10% formalin, phosphate buffer, and sodium citrate buffer were
purchased from Sigma-Aldrich, Germany, and all chemicals were used
without further purification. Enzyme kits were obtained from the Randox
Laboratory (Crumlin, United Kingdom).
+ Open protocol
+ Expand
7

Immunofluorescent Detection of Desmoglein-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
As indicated, excised vaginas were placed in formaldehyde and paraffin embedded and 10μm tissue sections were mounted on glass slides and de-paraffinized by sequential immersion in 100% xylene, 100% ethanol, 96% ethanol, and sterile DEPC-treated water. Antigen retrieval was performed using 10mM sodium citrate buffer (pH 6.0) containing 0.05% Tween 20 (both Sigma-Aldrich) (20 minutes at 95°C). After 3 PBS washes, sections were incubated overnight with 10% normal donkey serum (Abcam, Cambridge MA) at 4°C, incubated 1 h at ambient temperate with rabbit anti-desmoglein-1 (clone EPR6766(B)), washed, and incubated 1 h with AlexaFluor® 488-labeled donkey anti-rabbit IgG labeled (both antibodies Abcam) (all antibodies were diluted in PBS with 1% BSA and 0.05% Tween 20). Sections were stained with DAPI, and evaluated by confocal microscopy for relative expression of DSG1a protein (defined by calculating pixel numbers per 100 μm2) using ImageJ software53 (link). To evaluate relative DSG1a protein expression, images were acquired using identical parameters and their contrast altered equally (investigators performing such measurements were blinded to study group designation).
+ Open protocol
+ Expand
8

Immunohistochemistry of Advanced Glycation End-Products

Check if the same lab product or an alternative is used in the 5 most similar protocols
BP samples are from the ex vivo serum incubation study; rat subcutaneous explants were fixed in formalin (10%, v:v) for 24 to 72 h and embedded in paraffin. Five-µm-thick sections were cut via microtome and mounted on high-adherence glass microscope slides. Antigen retrieval was accomplished by 30 min incubation in 1× sodium citrate buffer (Sigma-Aldrich) at boiling temperature. Anti-AGE (Abcam; #ab23722, 1:5,000 dilution), anti-CML (Abcam #ab27684, 1:1,000 dilution), anti-HSA (Abcam #ab10241, 1:2,000 dilution), and anti-osteopontin (Abcam #ab8448, 1:2,000 dilution) were diluted in DAKO primary antibody diluent (Agilent Technologies, Santa Clara, CA, USA) and applied to sections overnight (16 to 18 h) at 4°C under gentle orbital shaking. DAKO HRP polymer-conjugated anti-rabbit secondary antibodies (Agilent, #ab214880) were applied at room temperature for 1 h. Washes were accomplished using DAKO Wash Buffer (Agilent). IHC stains were developed for 8 min using 3,3′-diaminobenzidine tetrahydrochloride substrate (Abcam), and sections were counterstained for 3 min with Gill’s hematoxylin (Sigma-Aldrich). Slides were mounted using Permount mounting medium (Fisher Scientific) and visualized by 5× light microscopy.
+ Open protocol
+ Expand
9

Quantification of Cell Apoptosis by TUNEL

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell apoptosis was evaluated by terminal deoxy-nucleotidyl transferase dUTP nick-end labeling (TUNEL), as previously described [57 (link)]. Briefly, permeabilized cells were incubated in terminal deoxy-nucleotidyl transferase buffer (0.25 U/μl terminal transferase, 6 μM biotinylated dUTP, pH 7.5; all from Roche Farma, S.A, Madrid, Spain) for 1 hour 30 minutes at 37°C in a humidified chamber. The enzymatic reaction was stopped by 15 minutes of incubation in 300 mM NaCl (Sigma-Aldrich) and 30 mM sodium citrate buffer (Sigma-Aldrich). Following an additional rinse in PBS, cultures were incubated for 30 minutes at room temperature with the avidin-biotin-peroxidase complex (1:100; Vector Laboratories, Burlingame, CA). Peroxidase activity was revealed by the 3,3′-diaminobenzidine chromogen (0.025%; Sigma-Aldrich) intensified with 0.08% NiCl2 in 30 mM Tris-HCl (pH 7.6) buffer containing 0.003% H2O2. The cell preparations were then dehydrated in ethanol (70%, 2 minutes; 80%, 2 minutes; 90%, 2 minutes; 95%, 2 minutes; 100%, 2 minutes), cleared in xylene (3 minutes), and mounted using DEPEX mounting medium (Sigma-Aldrich). Photomicrographs of TUNEL were recorded using a digital camera (Axiocam HRC; Carl Zeiss) adapted to an Axioskop 2 Plus fluorescent microscope (Carl Zeiss). For each well, 8 random fields were photographed and positive cells were scored.
+ Open protocol
+ Expand
10

Glycyrrhizic Acid Alleviates Diabetic Retinopathy

Check if the same lab product or an alternative is used in the 5 most similar protocols
All procedures with animals were performed in accordance with the Association for Research in Vision and Ophthalmology (ARVO) statement for use of animals in ophthalmic and vision research and they were approved by the institutional animal care and use committee of the College of Pharmacy, King Saud University. Adult male Sprague Dawley rats 7–10 weeks of age (200−220 g) were overnight fasted and a single bolus dose of streptozotocin (STZ) 55 mg/kg in 10 mM sodium citrate buffer, pH 4.5 (Sigma, St. Louis, MO), was injected intraperitoneally. Equal volumes of citrate buffer were injected in age-matched control rats. Rats were considered diabetic if their blood glucose was greater than 250 mg/dl.
Diabetic rats were divided into two groups: the rats in group I received normal drinking water without any supplementation and those in group II (curative treatment scheme, after disease induction) received drinking water supplemented with the potent HMGB1 inhibitor glycyrrhizic acid [52 (link)] (150 mg/kg/day, Santa Cruz Biotechnology Inc., Santa Cruz, CA) immediately after the establishment of diabetes [32 (link)-35 (link)]. After fou r weeks of diabetes, the rats were euthanized by an overdose of chloral hydrate, the eyes were removed, and the retinas were isolated and frozen immediately in liquid nitrogen and stored at -80 °C until analyzed.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!